Brain reward system activity in major depression and comorbid nicotine dependence

Journal of Pharmacology and Experimental Therapeutics

Volumn 302, Issue 3, 2002, Pages 1265-1271

  Cardenas, Laura ^a   Tremblay, Lescia K ^b   Naranjo, Claudio A ^c   Herrmann, Nathan ^b   Zack, Martin ^c   Busto, Usoa E ^a,c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMPHETAMINE; DOPAMINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOPAMINE RELEASE; DOUBLE BLIND PROCEDURE; FEMALE; HAMILTON SCALE; HUMAN; MALE; NEUROMODULATION; NEUROPSYCHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; REWARD; TOBACCO DEPENDENCE; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AFFECT; AGED; AGING; ARYL HYDROCARBON HYDROXYLASES; BRAIN; CARBON MONOXIDE; CYTOCHROME P-450 ENZYME SYSTEM; DEPRESSIVE DISORDER; DEXTROAMPHETAMINE; DOPAMINE UPTAKE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MIXED FUNCTION OXYGENASES; PSYCHIATRIC STATUS RATING SCALES; REWARD; SEX CHARACTERISTICS; SMOKING; TOBACCO USE DISORDER;

EID: 0036721408     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.302.3.1265     Document Type: Article

References (40)

1. Depression and the dynamics of smoking: A national perspective
2. The effects of nicotine on neural pathways implicated in depression: A factor in nicotine addiction?
3. (11C)Raclopride PET technique used to assess the dopaminergic response to acute tobacco smoking in humans
4. What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience?
5. Psychiatric comorbidity of smoking and nicotine dependence
6. The mesolimbic dopamine system is implicated in the reinforcing effects of nicotine
7. Molecular and cellular aspects of nicotine abuse
8. The reinforcing properties of amphetamine in overweight subjects and subjects with depression
9. Role of dopamine in the behavioural actions of nicotine related to addiction
10. Utility of subjective-effects measurements in assessing abuse liability of drugs in humans
11. Methods for the assessment of abuse liability of psychomotor stimulants and anorectic agents in humans
12. Smoking cessation and the course of major depression: A follow up study
13. Smoking, smoking cessation and major depression
14. Heavy smokers, smoking cessation and clonidine. Results of a double-blind, randomized trial
15. A rating scale for depression
16. The Fagerström test for nicotine dependence: A revision of the Fagerström tolerance questionnaire
17. Anhedonia in schizophrenic, depressed, or alcohol-dependent patients - Neurobiological correlates
18. Human abuse liability assessment by measurement of subjective and physiological effects. Testing for abuse liability of drugs in humans
19. Subjective and physiological effects of intravenous nicotine and cocaine in cigarette-smoking cocaine abusers
20. Heart attacks, smoking and the nicotine patch
21. Issues and recommendations regarding use of the Beck Depression Inventory
22. Smoking and major depression
23. Interactive effects of depressive symptoms, nicotine dependence and weight change on late smoking relapse
24. Drugs of abuse: Anatomy, pharmacology and function of reward pathways
25. Drug abuse: Hedonic homeostatic dysregulation
26. Postcocaine anhedonia: An animal model of cocaine withdrawal
27. Dual diagnosis and treatment: Substance abuse and comorbid medical and psychiatric disorders
28. Cigarette smoking among adults-United States, 1999
29. Nicotine metabolism defect reduces smoking
30. Nicotinic receptors in the brain: Links between molecular biology and behavior
31. Amphetamine-induced dopamine release greater in ventral than dorsal striatum
32. Drug dependence as a disorder of neural plasticity: Focus on dopamine and glutamate
33. Biological aspects of the link between smoking and depression
34. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression
35. Probing the brain reward system function in major depressive disorder: Altered response to d-amphetamine
36. Does nicotine release brain dopamine in conscious, nonsensitized monkeys?
37. Inhibition of nicotine metabolism defect reduces smoking
38. Loss of acute nicotine tolerance and severity of cigarette withdrawal
39. Nicotine addiction and the lure of reward